The Ultimate Human with Gary Brecka 182. Brigham Buhler: The Peptide Safety Data Reveals 75,000+ Patients With Zero Adverse Events
81 snips
Jul 10, 2025 
Brigham Buhler, a healthcare advocate from the White House, discusses the future of healthcare through the lens of peptides and biological optimization. He highlights remarkable safety data from over 75,000 patients, revealing zero adverse events compared to pharmaceuticals. The conversation touches on the significant shift in perceptions around peptides, previously deemed controversial. Buhler emphasizes the importance of informed choices in health and the potential for AI to revolutionize healthcare, particularly in early disease detection.
AI Snips
Chapters
Transcript
Episode notes
FDA Lacks Peptide Knowledge
- FDA officials lacked clinical need understanding of peptides, showing an educational gap.
- The FDA is cautious due to influence from chemical and pharma industry lobbying.
Peptides Safer than Drugs
- Peptides have much better safety and risk profiles than conventional drugs.
- Secretary Kennedy's pro-peptide stance signals a policy shift away from peptide bans.
Thriving Beyond Disease
- People want more than disease management; they want to thrive physically and mentally.
- Physician-supervised peptides can help people achieve optimal health and function.